TD Waterhouse Canada’s ProMIS Neurosciences PMN Stock Holding History

TD Waterhouse Canada’s Portfolio PMN Stock Details PMN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$66	Hold	5	–	–	﹤0.01%	2335
2026 Q1	$65	Sell	5 -20	-80%	-$298	﹤0.01%	2246
2025 Q4	$170	Sell	25 -13	-34%	-$127	﹤0.01%	1947
2025 Q3	$422	Buy	38 +33	+660%	+$457	﹤0.01%	1942
2025 Q2	$64	Hold	5	–	–	﹤0.01%	1925
2025 Q1	$94	Hold	5	–	–	﹤0.01%	1868
2024 Q4	$126	Hold	5	–	–	﹤0.01%	1876
2024 Q3	$163	Hold	5	–	–	﹤0.01%	1799
2024 Q2	$202	Buy	+5	New	+$234	﹤0.01%	1813
2024 Q1	–	Sell	-6	Closed	-$281	–	1903
2023 Q4	$281	Hold	6	–	–	﹤0.01%	1622
2023 Q3	$391	Hold	6	–	–	﹤0.01%	1613
2023 Q2	$745	Hold	6	–	–	﹤0.01%	1627
2023 Q1	$946	Hold	6	–	–	﹤0.01%	1604
2022 Q4	$900	Hold	6	–	–	﹤0.01%	1569
2022 Q3	$1.21K	Buy	+6	New	+$884	﹤0.01%	1560

Other funds holding PMN

Jupiter Topco New York $245B AUM

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

ABG

Ally Bridge Group New York $113M AUM 245.92% 1-Year Est. Return

TECP

Trails Edge Capital Partners Atlanta, Georgia $630M AUM

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Yu Fan $108M AUM 137.54% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return

SCM

Squadron Capital Management Westmont, Illinois $322M AUM

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

TD Waterhouse Canada's PMN Position: Q2 2026 in Review

TD Waterhouse Canada held its ProMIS Neurosciences (PMN) position steady in Q2 2026 at 5 shares worth $66. The position accounts for ﹤0.01% of the portfolio, ranked #2335.

TD Waterhouse Canada first reported a position in PMN in Q3 2022 and has held it in 15 quarters since. The position peaked at $1.21K in Q3 2022. 27 funds tracked by Wall St. Rank hold PMN as of Q2 2026.

TD Waterhouse Canada held 5 shares of ProMIS Neurosciences worth $66 as of Q2 2026.
TD Waterhouse Canada left its ProMIS Neurosciences share count unchanged in Q2 2026.
ProMIS Neurosciences made up ﹤0.01% of TD Waterhouse Canada's portfolio in Q2 2026, its #2335 holding.
TD Waterhouse Canada first reported a position in ProMIS Neurosciences in Q3 2022 and has held it in 15 quarters since.
TD Waterhouse Canada's ProMIS Neurosciences position peaked at $1.21K in Q3 2022.
27 funds tracked by Wall St. Rank held ProMIS Neurosciences as of Q2 2026.

Based on TD Waterhouse Canada's 13F filing for Q2 2026, filed 27 Jul 2026.